Trinity Biotech plc
NASDAQ:TRIBMedical - Diagnostics & Research
-$0.51 today
- Market cap
- $117.96M
- Beta
- 1.00
- P/E (TTM)
- -0.1
- EPS (TTM)
- -$60.27
Volume 0.00M
Average 1.34M
TRIB Change in Working Capital
Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.
Trinity Biotech plcNASDAQ: TRIB
Change in Working Capital · Q4 FY2025 · quarter ended Dec 2025
Change in working capital dips below year-ago levels
Q4 FY2025 change in working capital of $1.73M fell 79.8% year over year, behind the +3.8% change in trailing-twelve-month change in working capital. Sequentially, it rose 213.8% from the prior quarter.
Context
- Change in working capital amounted to 16.1% of revenue in FY2025, up 6.0 pp from a year earlier.
- Change in working capital increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -79.8% toward the trailing-twelve-month pace of +3.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Change in Working Capital history
USD · from the cash flow
- Latest · FY2025
- 7.03M USD
- Year-over-year change
- +13.6%
| Period | Period end | Change in Working Capital | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 7.03M | +13.6% |
| FY2024 | 2024-12-31 | 6.19M | +329.8% |
| FY2023 | 2023-12-31 | (2.69M) | -62.0% |
| FY2022 | 2022-12-31 | (1.66M) | -866.3% |
| FY2021 | 2021-12-31 | (172K) | — |
Change in Working Capital vs competitors
How TRIB compares with its peers on the latest reported figures
No competitor Change in Working Capital figures are available to compare.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 875K | (41.01M) | (24.02M) | (31.79M) | (37.38M) |
| Depreciation & Amortization | 2.74M | 2.33M | 1.78M | 1.87M | 2.68M |
| Deferred Income Tax | (167K) | (192K) | (59K) | 486K | 199K |
| Stock-Based Compensation | 1.1M | 1.76M | 2.07M | 1.32M | 324K |
| Change in Working Capital | (172K) | (1.66M) | (2.69M) | 6.19M | 7.03M |
| Accounts Receivables | 6.24M | (966K) | 1.05M | (2.37M) | 4.92M |
| Inventory | (4.41M) | (877K) | (971K) | (1.74M) | 90K |
| Accounts Payables | (7.59M) | 181K | (2.77M) | 8.19M | 0 |
| Other Working Capital | 5.59M | 7.57M | (478K) | 10.3M | 2.02M |
| Other Non-Cash Items | 8.86M | 37.85M | 11.37M | 17.74M | 21.21M |
| Operating Cash Flow | 13.24M | (921K) | (11.56M) | (4.19M) | (5.93M) |
| Capital Expenditures | (8.69M) | (5.98M) | (803K) | (10.06M) | (6.22M) |
| Acquisitions (Net) | 0 | 0 | 28.16M | (12.9M) | 0 |
| Purchases of Investments | 0 | 0 | (700K) | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (6.88M) | (4.88M) | (1.9M) | (9.66M) | (6.14M) |
| Investing Cash Flow | (8.69M) | (5.98M) | 24.76M | (22.97M) | (6.22M) |
| Debt Repayment | (2.94M) | (27.04M) | (7.37M) | 27.67M | 11.81M |
| Common Stock Issued | 0 | 25.34M | 0 | 7.39M | 547K |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (3.08M) | (10.61M) | (8.67M) | (6.25M) | (308K) |
| Financing Cash Flow | (6.02M) | (12.32M) | (16.04M) | 28.81M | 12.05M |
| Effect of Forex Changes | 55K | (112K) | (44K) | (175K) | 71K |
| Net Change in Cash | (1.42M) | (19.33M) | (2.89M) | 1.48M | (29K) |
| Free Cash Flow | 4.55M | (6.9M) | (12.36M) | (14.26M) | (12.15M) |
Trinity Biotech plc
NASDAQ:TRIB
Intrinsic Alpha fair value
Locked
Current Price
$5.83
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.